Empirical Financial Services, LLC D.B.A. Empirical Wealth Management Amneal Pharmaceuticals, Inc. Transaction History
Empirical Financial Services, LLC D.B.A. Empirical Wealth Management
- $4.37 Billion
- Q2 2025
A detailed history of Empirical Financial Services, LLC D.B.A. Empirical Wealth Management transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Empirical Financial Services, LLC D.B.A. Empirical Wealth Management holds 103,472 shares of AMRX stock, worth $1.01 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
103,472
Previous 89,598
15.48%
Holding current value
$1.01 Million
Previous $750,000
11.6%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding AMRX
# of Institutions
249Shares Held
145MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA17.6MShares$172 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$121 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$115 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$110 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$55 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.48B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...